[1]
Iung B, Delgado V, Rosenhek R, et al. Contemporary presentation and management of valvular heart disease: the EURObservational Research Programme Valvular Heart Disease II Survey. Circulation 2019; 140: 1156−1169. doi:
10.1161/CIRCULATIONAHA.119.041080
[2]
El Sabbagh A, Reddy YNV, Nishimura RA. Mitral valve regurgitation in the contemporary era: insights into diagnosis, management, and future directions. JACC Cardiovasc Imaging 2018; 11: 628−643. doi:
10.1016/j.jcmg.2018.01.009
[3]
Kihara Y, Sasayama S, Miyazaki S, et al. Role of the left atrium in adaptation of the heart to chronic mitral regurgitation in conscious dogs. Circ Res 1988; 62: 543−553. doi:
10.1161/01.RES.62.3.543
[4]
Tribouilloy C, Grigioni F, Avierinos JF, et al. Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. J Am Coll Cardiol 2009; 54: 1961−1968. doi:
10.1016/j.jacc.2009.06.047
[5]
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2022; 43: 561−632. doi:
10.1093/eurheartj/ehab395
[6]
Essayagh B, Antoine C, Benfari G, et al. Prognostic implications of left atrial enlargement in degenerative mitral regurgitation. J Am Coll Cardiol 2019; 74: 858−870. doi:
10.1016/j.jacc.2019.06.032
[7]
Rusinaru D, Tribouilloy C, Grigioni F, et al. Left atrial size is a potent predictor of mortality in mitral regurgitation due to flail leaflets: results from a large international multicenter study. Circ Cardiovasc Imaging 2011; 4: 473−481. doi:
10.1161/CIRCIMAGING.110.961011
[8]
Cheng S, Fernandes VR, Bluemke DA, et al. Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging 2009; 2: 191−198. doi:
10.1161/CIRCIMAGING.108.819938
[9]
Donekal S, Venkatesh BA, Liu YC, et al. Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort: the Multi-Ethnic Study of Atherosclerosis (MESA) study. Circ Cardiovasc Imaging 2014; 7: 292−302. doi:
10.1161/CIRCIMAGING.113.001073
[10]
Boyle AJ, Shih H, Hwang J, et al. Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp Gerontol 2011; 46: 549−559. doi:
10.1016/j.exger.2011.02.010
[11]
Fujimoto N, Hastings JL, Bhella PS, et al. Effect of ageing on left ventricular compliance and distensibility in healthy sedentary humans. J Physiol 2012; 590: 1871−1880. doi:
10.1113/jphysiol.2011.218271
[12]
Arbab-Zadeh A, Dijk E, Prasad A, et al. Effect of aging and physical activity on left ventricular compliance. Circulation 2004; 110: 1799−1805. doi:
10.1161/01.CIR.0000142863.71285.74
[13]
Redfield MM, Jacobsen SJ, Borlaug BA, et al. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 2005; 112: 2254−2262. doi:
10.1161/CIRCULATIONAHA.105.541078
[14]
Pan NH, Tsao HM, Chang NC, et al. Aging dilates atrium and pulmonary veins: implications for the genesis of atrial fibrillation. Chest 2008; 133: 190−196. doi:
10.1378/chest.07-1769
[15]
Rønningen PS, Berge T, Solberg MG, et al. Sex differences and higher upper normal limits for left atrial end-systolic volume in individuals in their mid-60s: data from the ACE 1950 Study. Eur Heart J Cardiovasc Imaging 2020; 21: 501−507. doi:
10.1093/ehjci/jeaa004
[16]
McManus DD, Xanthakis V, Sullivan LM, et al. Longitudinal tracking of left atrial diameter over the adult life course: clinical correlates in the community. Circulation 2010; 121: 667−674. doi:
10.1161/CIRCULATIONAHA.109.885806
[17]
Avierinos JF, Tribouilloy C, Grigioni F, et al. Impact of ageing on presentation and outcome of mitral regurgitation due to flail leaflet: a multicentre international study. Eur Heart J 2013; 34: 2600−2608. doi:
10.1093/eurheartj/eht250
[18]
Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015; 16: 233−270. doi:
10.1093/ehjci/jev014
[19]
Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2013; 14: 611−644. doi:
10.1093/ehjci/jet105
[20]
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143: e72−e227. doi:
10.1161/CIR.0000000000000923
[21]
Namazi F, van der Bijl P, Vo NM, et al. Sex differences in prognosis of significant secondary mitral regurgitation. ESC Heart Fail 2021; 8: 3539−3546. doi:
10.1002/ehf2.13503
[22]
[23]
Kammerlander AA, Donà C, Nitsche C, et al. Sex differences in left ventricular remodeling and outcomes in chronic aortic regurgitation. J Clin Med 2020; 9: 4100. doi:
10.3390/jcm9124100
[24]
Tastet L, Kwiecinski J, Pibarot P, et al. Sex-related differences in the extent of myocardial fibrosis in patients with aortic valve stenosis. JACC Cardiovasc Imaging 2020; 13: 699−711. doi:
10.1016/j.jcmg.2019.06.014
留言 (0)